Aetion Inc. – Women-Led Health Tech Company Driving Real-World Results Forward
Aetion Chief Science Officer, Nicolle Gatto, Ph.D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and development activities as well as regulatory decisions to inform healthcare’s most critical decisions, advance access to medications, and ultimately improve patient care.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Vaccine. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Vaccine and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Vaccine?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Aetion Chief Science Officer, Nicolle Gatto, Ph.D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and development activities as wel…
- Key Point: Nicolle is an epidemiologist with 20 years of industry experience.
- Key Point: She serves as a senior scientific voice ensuring appropriate and principled use of real-world data/evidence.
- Key Point: She received her PhD from Columbia University in New York City.
- Key Point: Prior to Aetion, Nicolle was the Group Head for Vaccines and Oncology with the Epidemiology Group at Pfizer.
Nicolle is an epidemiologist with 20 years of industry experience. She serves as a senior scientific voice ensuring appropriate and principled use of real-world data/evidence. She received her PhD from Columbia University in New York City. Prior to Aetion, Nicolle was the Group Head for Vaccines and Oncology with the Epidemiology Group at Pfizer. Nicolle is a Fellow of the International Society for Pharmacoepidemiology and an Adjunct Assistant Professor of Epidemiology at Columbia University and Tulane, teaching courses in pharmacoepidemiology, causal inference and confounding control methods.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



